Label: DHC ACNE SPOT THERAPY- sulfur cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated February 28, 2022

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active Ingredient

    Sulfur 3%

  • Purpose

    Acne treatment

  • Uses

    For the management of acne. Helps clear up acne blemishes.

  • Warnings

    For external use only

    • When using this product skin irritation and dryness is more likely to occur if used with another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
    • Avoid contact with eyes. If excessive skin irritation develops or increases, discontinue use and consult a doctor.

    • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

    Do not use on

    • Broken skin
    • Large areas of the skin

    When using this product

    • Apply only to areas with acne
  • Directions

    Cleanse skin thoroughly and tone before applying. Cover the affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

  • Inactive Ingredients

    water, butylene glycol, isononyl isononanoate, cetearyl alcohol, sorbitan stearate, ceteareth-20, phenoxyethanol, sucrose cocoate, xanthan gum, sodium citrate, citric acid, allantoin, disodium EDTA, magnesium ascorbyl phosphate, tocopherol, sodium hydroxide, brassica campestris (rapeseed) seed oil, glycyrrhiza glabra (licorice) root extract, camellia sinensis leaf extract, royal jelly extract, scutellaria baicalensis root extract, houttuynia cordata extract, perilla ocymoides leaf extract, aloe barbadensis leaf extract

  • Questions or Comments?

    800-DHC-CARE (342-2273)
    dhccare.com

  • SPL UNCLASSIFIED SECTION

    Distributed by DHC USA Inc.
    Mechanicsburg, PA 17050

  • PRINCIPAL DISPLAY PANEL - 15 g Tube Box

    DHC

    Acne
    Spot Therapy

    Acne Treatment

    .52 oz. (15 g) Net wt.

    PRINCIPAL DISPLAY PANEL - 15 g Tube Box
  • INGREDIENTS AND APPEARANCE
    DHC ACNE SPOT THERAPY 
    sulfur cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63433-389
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Sulfur (UNII: 70FD1KFU70) (Sulfur - UNII:70FD1KFU70) Sulfur6 mg  in 0.2 g
    Inactive Ingredients
    Ingredient NameStrength
    Water (UNII: 059QF0KO0R)  
    Butylene Glycol (UNII: 3XUS85K0RA)  
    Isononyl Isononanoate (UNII: S4V5BS6GCX)  
    Cetostearyl Alcohol (UNII: 2DMT128M1S)  
    Sorbitan Monostearate (UNII: NVZ4I0H58X)  
    Sodium Citrate, Unspecified Form (UNII: 1Q73Q2JULR)  
    Citric Acid Monohydrate (UNII: 2968PHW8QP)  
    Phenoxyethanol (UNII: HIE492ZZ3T)  
    Xanthan Gum (UNII: TTV12P4NEE)  
    Allantoin (UNII: 344S277G0Z)  
    .Alpha.-Tocopherol (UNII: H4N855PNZ1)  
    Brassica Rapa Subsp. Oleifera Oil (UNII: N4G8379626)  
    Magnesium Ascorbyl Phosphate (UNII: 0R822556M5)  
    Glycyrrhiza Glabra (UNII: 2788Z9758H)  
    Royal Jelly (UNII: L497I37F0C)  
    Green Tea Leaf (UNII: W2ZU1RY8B0)  
    Houttuynia Cordata Flowering Top (UNII: RH041UUZ22)  
    Scutellaria Lateriflora Top (UNII: C6CNB75R61)  
    Perilla Frutescens Leaf (UNII: T4L5881Y68)  
    Aloe Vera Leaf (UNII: ZY81Z83H0X)  
    Edetate Disodium (UNII: 7FLD91C86K)  
    Sodium Hydroxide (UNII: 55X04QC32I)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:63433-389-0015 g in 1 TUBE; Type 0: Not a Combination Product01/01/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH FINALpart333D01/01/2018
    Labeler - DHC USA Incorporated (004087554)
    Registrant - ABBE Laboratories, Inc. (781745286)
    Establishment
    NameAddressID/FEIBusiness Operations
    ABBE Laboratories, Inc.781745286MANUFACTURE(63433-389)